CTNND1 and prostate cancer: We currently investigated the relationship between δ-catenin and EGFR in order to delineate the potential connection between the enhanced EGFR expression in hormone refractory prostate cancer and the reciprocity of increased δ-catenin and decreased p120ctn expression during late stage prostate cancer.